![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Fresenius Kabi Oncology Limited Kalyani In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Ropivacaine hydrochloride monohydrate, Alternate process, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-130 - Rev 00
This Chemical Type CEP, issued on September 14, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2335 associated with this CEP further emphasizes